Media-OutReach Newswire The Lancet Neurology publishes positive results of AFFiRiS' Phase 1 trial with PD01A in Parkinson’s disease patients
Media-OutReach Newswire Rewardz StayWoW@home Corporate Wellness Program: First Page Digital & NTUC First Campus’ Secret to Beat Work-from-home Burnout
Media-OutReach Newswire Jones Day Advises GenScript Biotech Corporation on $423.8 million Initial Public Offering and Spin-off of Subsidiary Legend Biotech Corporation